JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
31 hedge funds and large institutions have $11M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 30 → 31 (+1)
Holders
31
Holding in Top 10
–
Calls
$264K
Puts
$55K
Top Buyers
| 1 | +$1.06M | |
| 2 | +$891K | |
| 3 | +$432K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$369K |
| 5 |
Morgan Stanley
New York
|
+$223K |
Top Sellers
| 1 | -$577K | |
| 2 | -$467K | |
| 3 | -$434K | |
| 4 |
Renaissance Technologies
New York
|
-$137K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$26.9K |